These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9311440)

  • 21. Paclitaxel activity in anthracycline refractory breast cancer patients.
    Vici P; Di Lauro L; Conti F; Capomolla E; Gionfra T; Amodio A; Lopez M
    Tumori; 1997; 83(3):661-4. PubMed ID: 9267484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
    Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
    Holmes FA
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Moore DH; Blessing JA; McQuellon RP; Thaler HT; Cella D; Benda J; Miller DS; Olt G; King S; Boggess JF; Rocereto TF
    J Clin Oncol; 2004 Aug; 22(15):3113-9. PubMed ID: 15284262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
    J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-agent paclitaxel by 3-hour infusion in the treatment of non-small cell lung cancer: links between p53 and K-ras gene status and chemosensitivity.
    Rosell R; González-Larriba JL; Alberola V; Molina F; Monzó M; Benito D; Pérez JM; de Anta JM
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):12-8. PubMed ID: 8553077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Gershenson DM; McGehee R
    J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.
    Kohn EC; Sarosy G; Bicher A; Link C; Christian M; Steinberg SM; Rothenberg M; Adamo DO; Davis P; Ognibene FP
    J Natl Cancer Inst; 1994 Jan; 86(1):18-24. PubMed ID: 7505830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel in the treatment of carcinoma of the esophagus.
    Ajani JA; Ilson DH; Daugherty K; Kelsen DP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):35-40. PubMed ID: 7541155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
    Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
    Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
    Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
    Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
    Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer.
    Machida H; Moeini A; Ciccone MA; Mostofizadeh S; Takiuchi T; Brunette LL; Roman LD; Matsuo K
    Am J Clin Oncol; 2018 Sep; 41(9):851-860. PubMed ID: 28763329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.